pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
carbidopa
Carbidopa Oceanside (carbidopa)
Parkinson's Disease
Bausch Health Americas Inc
112 catalysts
Marketed
dexmethylphenidate hydrochloride ER
Dexmethylphenidate Hydrochloride (dexmethylphenidate hydrochloride)
Attention Deficit Hyperactivity Disorder (ADHD)
Granules Pharma LLC
34 catalysts
Marketed
setmelanotide
Imcivree (setmelanotide)
Obesity
$RYTMRHYTHM PHARMACEUTICALS, INC.
6 catalysts
← prev
page 18 of 231
next →
131
Pain89
Neurology1
Marketed
OPUVIZ
OPUVIZ (AFLIBERCEPT-YSZY)
Samsung Bioepis Co Ltd
4 catalysts
Marketed
(foscarbidopa + foslevodopa)
Vyalev ((foscarbidopa + foslevodopa))
Parkinson's Disease
$ABBVAbbVie Inc.
2 catalysts
Marketed
EPHEDRINE SULFATE
EPHEDRINE SULFATE (EPHEDRINE SULFATE)
Fresenius Kabi USA LLC
1 catalysts
Marketed
VALGANCICLOVIR HYDROCHLORIDE
VALGANCICLOVIR HYDROCHLORIDE (VALGANCICLOVIR HYDROCHLORIDE)
Cytomegalovirus (CMV) Retinitis
Novadoz Pharmaceuticals LLC
1 catalysts
Marketed
VIGABATRIN
VIGABATRIN (VIGABATRIN)
Complex Partial Seizure
Novadoz Pharmaceuticals LLC
103 catalysts
Marketed
PROSCAR
PROSCAR (FINASTERIDE)
3-oxo-5-alpha-steroid 4-dehydrogenase 2
$OGNOrganon & Co.
41 catalysts
Marketed
risankizumab
Skyrizi (risankizumab-rzaa)
Psoriatic Arthritis
$ABBVAbbVie Inc.
23 catalysts
Marketed
CABERGOLINE
CABERGOLINE (CABERGOLINE)
Hyperprolactinaemia
Ingenus Pharmaceuticals LLC
9 catalysts
Marketed
fedratinib
Inrebic (fedratinib)
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
Bristol-Myers Squibb Co
7 catalysts
Marketed
pacritinib
Vonjo (pacritinib)
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
Sobi Inc
6 catalysts
Marketed
LISDEXAMFETAMINE DIMESYLATE
LISDEXAMFETAMINE DIMESYLATE (LISDEXAMFETAMINE DIMESYLATE)
Attention Deficit Hyperactivity Disorder (ADHD)
Actavis Elizabeth LLC
5 catalysts
Marketed
momelotinib dihydrochloride
Ojjaara (momelotinib dihydrochloride)
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
GlaxoSmithKline LLC
4 catalysts
Marketed
polatuzumab vedotin
Polivy (polatuzumab vedotin-piiq)
Diffuse Large B-Cell Lymphoma
Genentech Inc
4 catalysts
Marketed
DESOGESTREL AND ETHINYL ESTRADIOL
DESOGESTREL AND ETHINYL ESTRADIOL (DESOGESTREL)
Annora Pharma Pvt Ltd
1 catalysts
Marketed
ivacaftor
Kalydeco (ivacaftor)
Cystic Fibrosis
$VERXVertex, Inc.
21 catalysts
Marketed
(ivacaftor + lumacaftor)
Orkambi ((ivacaftor + lumacaftor))
Cystic Fibrosis
$VERXVertex, Inc.
20 catalysts
Marketed
OXALIPLATIN
OXALIPLATIN (OXALIPLATIN)
Colon Cancer
Ingenus Pharmaceuticals LLC
4 catalysts
Marketed
MICAFUNGIN SODIUM
MICAFUNGIN SODIUM (MICAFUNGIN SODIUM)
Candida Peritonitis
Xellia Pharmaceuticals USA LLC
2 catalysts
Marketed
icotrokinra hydrochloride
Icotyde (icotrokinra hydrochloride)
Ulcerative Colitis
$JNJJOHNSON & JOHNSON
1 catalysts
Marketed
linerixibat
Lynavoy (linerixibat)
Pruritus
GlaxoSmithKline LLC
1 catalysts
Marketed
rimegepant sulfate ODT
Nurtec (rimegepant sulfate)
Rhinosinusitis
Calcitonin gene-related peptide type 1 receptor
$PFEPFIZER INC
10 catalysts
Marketed
Fluticasone Propionate Glenmark
Fluticasone Propionate (fluticasone propionate)
Non Allergic Rhinitis
Glenmark Pharmaceuticals Ltd
3 catalysts
Marketed
acamprosate calcium DR
Acamprosate Calcium (acamprosate calcium)
Alcohol Use Disorder (AUD)
Appco Pharma LLC
1 catalysts
Marketed
Daptomycin Novo
Daptomycin (daptomycin)
Bacteremia
Xellia Pharmaceuticals USA LLC
9 catalysts
Marketed
MEFENAMIC ACID
MEFENAMIC ACID (MEFENAMIC ACID)
Pain
Belcher Pharmaceuticals LLC
8 catalysts
Marketed
ALLOPURINOL SODIUM
ALLOPURINOL SODIUM (ALLOPURINOL SODIUM)
Hikma Pharmaceuticals Plc
4 catalysts
Marketed
GEMCITABINE HYDROCHLORIDE
GEMCITABINE HYDROCHLORIDE (GEMCITABINE HYDROCHLORIDE)
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
DNA polymerase (alpha/delta/epsilon)Ribonucleoside-diphosphate reductase RR1
$JNJJOHNSON & JOHNSON
3 catalysts